The Latest Breaking News from Disease

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose.

It’s not only cholesterol that’s worrisome: Elevated levels of lipoprotein(a) increase your risk of heart attack and stroke.

For individuals from diverse backgrounds, managing heart disease effectively often depends on more than access to medical care — it requires culturally relevant education. Recent research reveals that adapting patient education to match cultural contexts can significantly improve health outcomes, offering hope in the fight against the world’s leading cause…

By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more likely than men to develop Alzheimer’s disease, even after accounting for women living longer.

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual MeetingGlobe NewswirePoster presentation at ASH

Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results.

The FIELD study at the University of Glasgow is investigating potential links between dementia and head impacts in sport.

Pop star Peter Andre has revealed he's booking a trip home to Australia to visit his sick mom after she was diagnosed with Parkinson's and Alzheimer's disease.

Researchers at the University of Basel’s Centre for Gastrointestinal and Liver Diseases, have linked fatty liver disease to sleep disruption. We explore the findings.